Compare MOD & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MOD | BIO |
|---|---|---|
| Founded | 1916 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.5B | 8.0B |
| IPO Year | 1995 | 1994 |
| Metric | MOD | BIO |
|---|---|---|
| Price | $194.66 | $386.11 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 4 |
| Target Price | $223.71 | ★ $339.75 |
| AVG Volume (30 Days) | ★ 1.2M | 236.0K |
| Earning Date | 05-19-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 142.61 |
| EPS | ★ 1.37 | N/A |
| Revenue | $1,352,500,000.00 | ★ $2,583,200,000.00 |
| Revenue This Year | $23.05 | $2.74 |
| Revenue Next Year | $21.83 | $3.20 |
| P/E Ratio | $134.56 | ★ N/A |
| Revenue Growth | N/A | ★ 0.65 |
| 52 Week Low | $111.18 | $236.73 |
| 52 Week High | $323.25 | $396.23 |
| Indicator | MOD | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 40.87 | 69.94 |
| Support Level | $170.21 | $287.41 |
| Resistance Level | $238.19 | $396.23 |
| Average True Range (ATR) | 9.94 | 11.10 |
| MACD | 0.36 | -0.93 |
| Stochastic Oscillator | 24.42 | 79.56 |
Modine Manufacturing Co provides thermal management solutions to diversified markets and customers. The company provides engineered heat transfer systems and heat transfer components for use in on- and off-highway original equipment manufacturer (OEM) vehicular applications in the United States. It offers powertrain cooling products, such as engine cooling assemblies, radiators, condensers, and charge air coolers; auxiliary cooling products, including power steering and transmission oil coolers. Its operating segments include Climate Solutions and Performance Technologies.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.